Sohinolol
Nazivi | |
---|---|
IUPAC naziv 5-[3-(tert-Butilamino)-2-hidroksipropoksi]-3,4-dihidro-1H-izohinolin-2-karbaldehid | |
Identifikacija | |
| |
3D model (Jmol) |
|
ChemSpider |
|
ECHA InfoCard | 100.057.113 |
PubChem[1][2] C ID |
|
UNII |
|
SMILES
| |
Svojstva | |
C17H26N2O3 | |
Molarna masa | 306,41 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Sohinolol je antagonist beta adrenergičkog receptora.[3]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Gries, J; Unger, L; Einig, H; Friedrich, L; Hofmann, HP; Kreiskott, H; Lehmann, HD; Von Philipsborn, G; Wuppermann, D; Zimmermann, F (1988). „Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol”. Arzneimittel-Forschung. 38 (9): 1271—9. PMID 2906243.
- п
- р
- у
Adrenergici
|
|
|
Drugi | |||||||
---|---|---|---|---|---|---|---|
|